文献速递肝胆胰外科围术期管理与 ERAS

术后阿片类药物使用与远端胰腺切除术后临床相关胰瘘相关

Postoperative narcotic use is associated with development of clinically relevant pancreatic fistulas after distal pancreatectomy.
PubMed 文献 · Surgery · 2017-12-18

这项回顾性分析纳入2011-2016年310例远端胰腺切除术患者,发现术后阿片类药物用量(以吗啡当量计)与临床相关术后胰瘘(CR-POPF)发生独立相关,每增加约100 mg吗啡当量,CR-POPF风险增加13%;胰腺癌病理则具保护作用。限制阿片类药物使用可能是减少CR-POPF的可行策略之一。

要点

  • 远端胰腺切除术后阿片类药物用量越高,临床相关胰瘘风险越高。
  • 每增加约100 mg吗啡当量,临床相关胰瘘风险增加13%。
  • 胰腺癌病理与临床相关胰瘘风险降低独立相关。

核心结论

  • 术后阿片类药物使用与远端胰腺切除术后临床相关胰瘘发生相关。
  • 限制阿片类药物使用可能是减少远端胰腺切除术后临床相关胰瘘的可行策略之一。

研究设计与样本

  • 回顾性分析2011-2016年连续远端胰腺切除术病例,共310例(机器人61%、开腹20%、腹腔镜19%)。
  • 术后阿片类药物用量换算为吗啡当量,胰瘘按国际胰腺外科研究组标准分级。
  • 采用多因素logistic回归,以临床相关术后胰瘘为因变量评估围术期变量。

主要发现

  • 临床相关术后胰瘘发生率为21.6%。
  • 临床相关胰瘘组中位总吗啡当量为577 mg,无临床相关胰瘘组为403 mg(P<.009)。
  • 临床相关胰瘘组吻合器离断比例较低(80% vs 90%,P=.025),胰腺癌比例较低(11% vs 35%,P<.001)。

关键数值与推荐

  • 临床相关术后胰瘘按国际胰腺外科研究组标准分级。
  • 单因素分析中,临床相关胰瘘与BMI、非吻合器离断、胰管缝扎、非胰腺癌病理、预防性奥曲肽及总吗啡当量>424 mg(队列中位数)相关。

临床怎么用

  • 远端胰腺切除术后应关注阿片类药物用量,在充分镇痛前提下尽量减少阿片类暴露。
  • 对阿片类药物用量较高的远端胰腺切除患者,需加强临床相关胰瘘的监测与预防。

局限性

  • 本研究为单中心回顾性分析,可能存在混杂与选择偏倚。
  • 阿片类药物用量与临床相关胰瘘的关联不能直接推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Various strategies to decrease postoperative pancreatic fistula after a distal pancreatectomy have proved unsuccessful. Because narcotics can cause spasm of the sphincter of Oddi and thereby increase pressure within the pancreatic duct stump, we hypothesized that increased narcotic use would be associated with increased occurrence of clinically relevant postoperative pancreatic fistula after distal pancreatectomy. METHODS: Retrospective analysis of consecutive distal pancreatectomies (2011-2016) was performed. Postoperative narcotic use was calculated in morphine equivalents. Postoperative pancreatic fistula was graded according to the International Study Group on Pancreatic Surgery. Perioperative variables were evaluated using multivariate logistic regression with clinically relevant postoperative pancreatic fistula as the dependent outcome. RESULTS: In the study, 310 distal pancreatectomies were analyzed (61% robotic, 20% open, 19% laparoscopic). Average age was 62 (53% female), and median total dose of morphine equivalents was 424 mg (interquartile range 242-768). Clinically relevant postoperative pancreatic fistula occurred in 21.6%. Clinically relevant postoperative pancreatic fistula and not clinically relevant postoperative pancreatic fistula cohorts were similar in most demographics and operative variables, but clinically relevant postoperative pancreatic fistula patients had fewer stapled transections (80 vs 90%, P=.025), less pancreatic cancers (11 vs 35%, P<.001), and greater median total morphine equivalents (577 vs 403 mg, P < .009). On univariate analysis, clinically relevant postoperative pancreatic fistula was associated with body mass index, nonstapled transection, suture ligation of the PD, a nonpancreatic cancer pathology, prophylactic octreotide, and total morphine equivalents >424 (cohort median). On multivariate analysis, only pancreatic cancer pathology was protective against a clinically relevant postoperative pancreatic fistula (odds ratio 0.24, confidence interval, 0.10-0.50, P=.001), while increasing total morphine equivalents were predictive of a clinically relevant postoperative pancreatic fistula (odds ratio 1.13, confidence interval, 1.01-1.27, P=.035) with a 13% increased risk for every approximate ≈100 mg increase in total morphine equivalents. CONCLUSION: In this retrospective analysis, postoperative narcotic use was associated with the development of clinically relevant postoperative pancreatic fistula after distal pancreatectomy. Limiting narcotic use may be one of the few available mitigating strategies against the development of a clinically relevant postoperative pancreatic fistula after distal pancreatectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kowalsky SJ, Zenati MS, Dhir M, et al. Postoperative narcotic use is associated with development of clinically relevant pancreatic fistulas after distal pancreatectomy. Surgery. 2017. PMID: 29269087. doi:10.1016/j.surg.2017.10.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。